The clause nobody reads until the shipment is already on the water
You are three months into your first serious export relationship. The sample order went well, the distributor wants a full consignment, and the freight forwarder is waiting on your confirmation. Then your insurance broker calls. The buyer, it turns out, has been assessed. The insurer will cover five thousand euros. The order is worth sixty thousand. The broker is apologetic. The policy, he explains, is working exactly as designed.
That is the moment trade credit insurance reveals its second face. The policy looked like a tool for growth. It is, in practice, a map with certain territories already colored in gray, and the coloring was done before you arrived.
Trade credit insurance is, at its core, a promise: ship goods to a buyer, and if that buyer fails to pay, the insurer covers a percentage of the loss. For exporters selling on 60- or 90-day terms, it is the difference between offering competitive payment windows and demanding cash in advance, which most foreign buyers simply will not accept. The insurance makes the credit possible. Without the credit, the deal does not happen.
But the policy that enables that trade also contains a structural logic that concentrates access. That logic is worth understanding before you sign.
How the discretionary limit quietly draws the map
Every whole-turnover trade credit policy, the kind that covers an exporter's entire debtor book rather than individual transactions, is built around two types of buyer approval: formal credit limits, which the insurer explicitly underwrites after reviewing a buyer's financials, and discretionary credit limits, which allow the exporter to extend small amounts of credit to buyers without seeking prior approval.
The discretionary limit is typically modest. Depending on the insurer and the policy, it might sit at something like fifteen thousand to thirty thousand euros per buyer. For a domestic transaction, that can be workable. For an export sale, where a single shipment of industrial components might be worth eighty thousand euros, it is often useless.
So the exporter applies for a formal credit limit on the foreign buyer. The insurer's credit analysts assess the buyer's payment history, their audited accounts, and whatever data the insurer's network can gather in that country. In markets where financial reporting is transparent and credit bureaus are well-established, this process works reasonably well. In markets where small and medium-sized buyers operate informally, where audited accounts are rare, or where the insurer has thin data coverage, the analyst does the only defensible thing: they decline the limit, or offer a figure so low it does not cover the order value.
The exporter has not been told they cannot sell to that buyer. They have simply been told that if they do, they will be doing it uninsured. And an uninsured export sale, to an unknown buyer in a market the exporter has never traded with before, is a risk most small manufacturers cannot absorb. So the sale does not happen.
Consider a specific case. A mid-sized Welsh packaging firm wants to sell to a distributor in Morocco. The distributor is profitable, has traded without incident for a decade, but files accounts that meet local requirements rather than IFRS standards and is not rated by any agency the insurer's model recognises. The insurer offers a limit of five thousand euros. The order is worth sixty thousand. The Welsh firm, which cannot afford to lose sixty thousand euros in a bad debt, walks away. The Moroccan distributor buys from a larger competitor that self-insures because it can absorb the loss. The Welsh firm does not enter the market at all.
That is not a hypothetical edge case. It is the ordinary arithmetic of how whole-turnover policies interact with frontier and emerging markets, repeated quietly across thousands of would-be export relationships every year.
What people get wrong: the insurer is not the villain
The temptation is to frame this as an industry failing its customers. That framing is too simple, and it leads to the wrong remedies.
Credit insurers are not development banks. They price risk to remain solvent across a portfolio, and declining a limit on a buyer they cannot adequately assess is rational, not malicious. The information asymmetry is real. A buyer in a market with weak credit infrastructure genuinely is harder to evaluate, and harder to evaluate means harder to insure. One cannot fault the actuary for the absence of reliable data.
The deeper problem is one of design fit. Whole-turnover policies were built around the trade patterns of exporters who sell repeatedly to many buyers in markets with deep credit data, something like a German automotive parts supplier moving goods to dozens of counterparties across Western Europe. They work poorly for a first-time exporter attempting a single new market with a single new buyer, precisely the situation where the insurance would be most valuable. The product was engineered for established trade corridors, then marketed as infrastructure for building new ones. Those are not the same thing.
Single-buyer or named-buyer policies exist as an alternative, and some export credit agencies offer political-risk-plus-commercial-risk cover for markets commercial insurers will not touch. But these products are more expensive per unit of cover, carry more administrative overhead, and in practice many smaller exporters learn they exist only after they have already been turned down. By then the distributor has found another supplier.
The premium structure that rewards the already-large
There is a secondary mechanism that compounds the access problem, and it operates through premium calculation rather than limit approval.
Whole-turnover premiums are typically expressed as a percentage of insured turnover, often somewhere in the range of 0.1 to 0.5 percent of annual sales run through the policy. On a ten-million-euro debtor book, even the upper end of that range is manageable. On a two-million-euro debtor book, the minimum annual premium that insurers require to make the policy worth administering can represent a disproportionate cost, sometimes eating several hundred basis points of margin on a thin-margin export product. The fixed cost of administration, like a tax, falls hardest on the smallest payer.
The result is a quiet tiering. Large exporters with diversified debtor books get favourable premium rates, broad coverage, and the insurer's genuine interest in finding ways to approve limits because the relationship is commercially valuable. Smaller exporters pay more relative to their turnover, get narrower coverage, and find the insurer less willing to invest analytical effort in approving limits on obscure buyers. It works rather like a library that charges its most occasional readers the highest membership fees, then wonders why they stop coming.
Ask yourself this: if the incentive the policy creates is to keep selling to the same buyers in the same markets where limits are already approved, what exactly is the insurance enabling?
Export growth requires the opposite of that. New buyers. New markets. Relationships that do not yet have a history. The whole-turnover policy, as structured, is quietly hostile to all three.
The shape of the problem, and who it actually locks out
Set the pieces together and a pattern emerges that is harder to dismiss than any individual case. The exporters most disadvantaged by trade credit insurance policy structure are smaller firms with turnover below the threshold where whole-turnover policies become economical; firms selling into markets where buyer-level credit data is thin, covering most of sub-Saharan Africa, parts of Southeast Asia, much of Latin America outside Brazil and Mexico; firms attempting their first export relationship with a new buyer rather than expanding an existing one; and firms in sectors where individual order values are large relative to annual turnover, making the discretionary limit effectively useless.
These are not fringe cases. They are precisely the firms that trade policy in most economies is nominally designed to help: first-time exporters, small and medium enterprises, companies targeting high-growth markets. The insurance architecture that underpins open-account trade was built for the exporters who needed it least, which is not an accident of history so much as a consequence of where the commercial incentives have always pointed.
Governments can negotiate market access agreements, cut tariffs, and fund trade missions. Useful, all of it. None of it moves the needle if the private insurance infrastructure that makes open-account credit viable closes its doors to the buyers those exporters are being encouraged to find. The gap between trade promotion and trade finance has never been especially glamorous policy territory. It is, for that reason, where the real obstruction tends to sit.